Not a good buy right now for an impatient investor: trend is still bearish (SMA_200 > SMA_20 > SMA_5) and momentum remains negative.
Price is only slightly above key support (S1 127.50); downside risk remains if support breaks, while upside first needs a reclaim of the pivot (141.15).
No Intellectia edge today (no AI Stock Picker / SwingMax signal), so there’s no strong timing catalyst to justify jumping in immediately.
Options positioning (OI put/call > 1) leans cautious/bearish and liquidity is extremely thin (0 volume), reducing confidence in sentiment signals.
Net: HOLD / do not initiate a new buy today; only becomes interesting after a clear rebound (reclaiming ~141) or a confirmed higher-low off support with improving MACD.
Technical Analysis
Trend: Bearish structure with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), indicating a sustained downtrend.
Momentum: MACD histogram at -3.553 (below zero) and still negative, suggesting bearish momentum persists even if it’s contracting.
RSI: RSI_6 at 24.945 (effectively oversold/very weak momentum); this can spark a short bounce, but it is not a trend-reversal confirmation by itself.
Levels:
Support: S1 ~127.50 (price 129.22 is close); next support S2 ~119.07.
Sentiment (Open Interest): Put/Call OI ratio = 1.19 (more puts than calls outstanding), typically signaling cautious-to-bearish positioning or hedging demand.
Activity/Liquidity: Today’s option volume is 0 (both calls and puts), so real-time options sentiment is not reliable.
Volatility: 30D IV ~32.83 vs historical volatility ~45.34 (options priced cheaper than realized moves recently); IV percentile ~49.4 (mid-range), not signaling extreme fear or euphoria.
Technical Summary
Sell
8
Buy
1
Positive Catalysts
Short-term technical bounce potential: RSI is deeply weak and price is sitting near first support (~127.5), which can attract dip-buying.
Pattern-based outlook provided: similarity model suggests a favorable next-month probability with +12.89% (model-based, not a confirmation).
Revenue growth remains positive YoY in the latest reported quarter (2026/Q3 +7.9%), showing demand hasn’t collapsed.
Neutral/Negative Catalysts
below expectations ($0.
and revenue ($244.1M) below consensus ($253.5M), which typically pressures near-term sentiment.
Financial Performance
Latest quarter: 2026/Q3.
Revenue: $244.08M, +7.90% YoY (top-line growth still intact).
Net income: $14.312M, -4.72% YoY (profit declined despite revenue growth).
EPS: $0.69, -4.17% YoY (earnings pressure).
Gross margin: 20.82%, down ~2.76% YoY (margin compression consistent with cost headwinds).
Takeaway: growth is present on revenue, but quality of growth is weakening due to margins/earnings slipping.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating trend or price target change data was provided, so recent Wall Street upgrades/downgrades cannot be confirmed from the dataset.
Wall Street-style pros (based on provided fundamentals/news): steady YoY revenue growth; potential mean-reversion bounce after heavy technical weakness.
Wall Street-style cons: recent quarter missed expectations; profitability and margins are trending down YoY; sector cost/demand pressures could persist.
Influential/Political trading: No recent congress trading data available; hedge funds and insiders shown as neutral with no significant recent trends.
Wall Street analysts forecast HWKN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HWKN is 200 USD with a low forecast of 200 USD and a high forecast of 200 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast HWKN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HWKN is 200 USD with a low forecast of 200 USD and a high forecast of 200 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 129.970
Low
200
Averages
200
High
200
Current: 129.970
Low
200
Averages
200
High
200
BWS Financial
Buy
maintain
$160 -> $200
AI Analysis
2025-08-01
Reason
BWS Financial
Price Target
$160 -> $200
AI Analysis
2025-08-01
maintain
Buy
Reason
BWS Financial raised the firm's price target on Hawkins to $200 from $160 and keeps a Buy rating on the shares after the company reported Q1 sales and EPS ahead of the firm's estimates even though the weather was not favorable. The firm expects synergies within water treatment and food and health sciences segments to provide a lift to current estimates, the analyst tells investors.
Raymond James
Bobby Zolper
Market Perform
initiated
2025-07-23
Reason
Raymond James
Bobby Zolper
Price Target
2025-07-23
initiated
Market Perform
Reason
Raymond James analyst Bobby Zolper initiated coverage of Hawkins with a Market Perform rating and no price target. The firm is cautious on the shares following the 700% rally since 20219. Hawkins is an 80-year-old business with limited long-term earnings growth in the low- to mid-teens range, the analyst tells investors in a research note. Raymond James views the stock's valuation as "less-than-compelling."
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HWKN
